Bellerophon Therapeutics, Inc. (BLPH)
OTCMKTS: BLPH · Delayed Price · USD
0.0544
-0.0027 (-4.73%)
Apr 19, 2024, 3:21 PM EDT - Market closed
Bellerophon Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.92 | 24.74 | 47.56 | 9.87 | 16.65 | 28.82 | 14.45 | 6.26 | 16.82 | 0 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 3 | 5.57 | 17.81 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 6.92 | 24.74 | 47.56 | 9.87 | 16.65 | 31.82 | 20.02 | 24.07 | 16.82 | 0 | Upgrade
|
| Cash Growth | -72.01% | -47.99% | 381.64% | -40.68% | -47.69% | 58.90% | -16.80% | 43.13% | - | - | Upgrade
|
| Other Current Assets | 0.64 | 0.72 | 0.52 | 0.51 | 0.75 | 3.76 | 6.48 | 5.39 | 10.87 | 1.55 | Upgrade
|
| Total Current Assets | 7.56 | 25.46 | 48.08 | 10.38 | 17.4 | 35.58 | 26.51 | 29.45 | 27.68 | 1.55 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.93 | 1.67 | 2.43 | 0.66 | 1.03 | 1.4 | 1.8 | 1.7 | 2.08 | Upgrade
|
| Other Long-Term Assets | 0.19 | 0.49 | 0.49 | 0.3 | 0.3 | 0.2 | 1.8 | 7.16 | 4.01 | 0 | Upgrade
|
| Total Long-Term Assets | 0.37 | 1.42 | 2.16 | 2.73 | 0.96 | 1.23 | 3.2 | 8.96 | 5.71 | 2.08 | Upgrade
|
| Total Assets | 7.94 | 26.88 | 50.24 | 13.11 | 18.36 | 36.81 | 29.7 | 38.41 | 33.39 | 3.64 | Upgrade
|
| Accounts Payable | 1.23 | 1.19 | 3.73 | 3.11 | 2.76 | 3.85 | 2.81 | 1.61 | 0.38 | 1.37 | Upgrade
|
| Current Debt | 0.2 | 0.75 | 0.7 | 0.66 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 3.97 | 3.11 | 6 | 3.82 | 4.78 | 3.23 | 3.69 | 6.46 | 10.08 | 12.62 | Upgrade
|
| Total Current Liabilities | 5.4 | 5.05 | 10.43 | 7.58 | 7.54 | 7.08 | 6.5 | 8.07 | 10.45 | 13.99 | Upgrade
|
| Long-Term Debt | 0 | 0.2 | 0.96 | 1.66 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 1.43 | 0 | 0.6 | 0.27 | 6.97 | 32.33 | 5.22 | 0 | 0 | 5.38 | Upgrade
|
| Total Long-Term Liabilities | 1.43 | 0.2 | 1.56 | 1.93 | 6.97 | 32.33 | 5.22 | 0 | 0 | 5.38 | Upgrade
|
| Total Liabilities | 5.4 | 5.26 | 11.99 | 9.52 | 14.5 | 39.4 | 11.71 | 8.07 | 10.45 | 19.37 | Upgrade
|
| Total Debt | 0.2 | 0.96 | 1.66 | 2.32 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt Growth | -78.74% | -42.47% | -28.36% | - | - | - | - | - | - | - | Upgrade
|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.05 | 0.59 | 0.57 | 0.32 | 0.13 | 0 | 0 | Upgrade
|
| Retained Earnings | -252.08 | -232.25 | -214.49 | -189.76 | -176.5 | -179.31 | -124.49 | -100.68 | -54.22 | -176.52 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0.02 | -1.25 | -0.86 | Upgrade
|
| Shareholders' Equity | 2.53 | 21.62 | 38.25 | 3.59 | 3.86 | -2.59 | 17.99 | 30.34 | 22.94 | -15.74 | Upgrade
|
| Total Liabilities and Equity | 7.94 | 26.88 | 50.24 | 13.11 | 18.36 | 36.81 | 29.7 | 38.41 | 33.39 | 3.64 | Upgrade
|
| Net Cash / Debt | 6.72 | 23.78 | 45.9 | 7.56 | 16.65 | 31.82 | 20.02 | 24.07 | 16.82 | 0 | Upgrade
|
| Net Cash / Debt Growth | -71.74% | -48.19% | 507.34% | -54.60% | -47.69% | 58.90% | -16.80% | 43.13% | - | - | Upgrade
|
| Net Cash Per Share | 0.70 | 2.50 | 5.89 | 1.68 | 3.84 | 12.25 | 19.95 | 29.43 | 1.41 | - | Upgrade
|
| Working Capital | 2.16 | 20.41 | 37.65 | 2.8 | 9.86 | 28.5 | 20.01 | 21.38 | 17.23 | -12.44 | Upgrade
|
| Book Value Per Share | 0.27 | 2.28 | 4.91 | 0.80 | 0.89 | -1.00 | 17.92 | 37.09 | 1.93 | -1.22 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.